Breast conservation treatment with radiation: An ongoing success story

Journal of Clinical Oncology

Volumn 28, Issue 5, 2010, Pages 709-717

  Solin, Lawrence J ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; EDITORIAL; HUMAN; MASTECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; ADJUVANT THERAPY; BIOLOGICAL MODEL; BREAST TUMOR; DECISION SUPPORT SYSTEM; FEMALE; INTERNET; NOMOGRAM; NOTE; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; SEGMENTAL MASTECTOMY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; INTERNET; MASTECTOMY, SEGMENTAL; MODELS, BIOLOGICAL; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77649219882     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.1164     Document Type: Editorial

References (40)

1. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
2. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002 (Pubitemid 35176242)
3. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002 (Pubitemid 35176241)
4. Schwartz GF, Veronesi U, Clough KB, et al: Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer 107:242-250, 2006
5. McGuire KP, Santillan A, Kaur P, et al: Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2669-2672, 2009
6. Katipamula R, Degnim AC, Hoskin T, et al: Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082-4088, 2009
7. Morrow M, Harris JR: More mastectomies: Is this what patients really want? J Clin Oncol 27:4038-4040, 2009
8. Bleicher RJ, Ciocca RM, Egleston BL, et al: Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209:180-187, 2009
9. Pengel KE, Loo CE, Teertstra HJ, et al: The impact of preoperative MRI on breast-conserving surgery of invasive cancer: A comparative cohort study. Breast Cancer Res Treat 116:161-169, 2009
10. Houssami N, Ciatto S, Macaskill P, et al: Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248-3258, 2008
11. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007
12. Sorbero MES, Dick AW, Beckjord EB, et al: Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597-1605, 2009
13. Sanghani M, Truong PT, Raad RA, et al: Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 28:718-722, 2010
14. Sanghani M, Balk E, Cady B, et al: Predicting the risk of local recurrence in patients with breast cancer. Am J Clin Oncol 30:473-480, 2007
15. Anderson SJ, Wapnir I, Dignam JL, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27:2466-2473, 2009
16. Solin LJ, Orel S, Hwang W-T, et al: Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26:386-391, 2008 (Pubitemid 351171689)
17. Pierce LJ, Griffith KA, Hayman JA, et al: Conservation surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys 61:1317-1327, 2005
18. Pass H, Vicini FA, Kestin LL, et al: Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 101:713-720, 2004 (Pubitemid 39030925)
19. Cabioglu N, Hunt KK, Buchholz TA, et al: Improving local control with breast-conserving therapy: A 27-year single-institution experience. Cancer 104:20-29, 2005 (Pubitemid 40847748)
20. Whelan TJ, Pignol J, Julian J, et al: Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancer. Int J Radiat Oncol Biol Phys 72:S28, 2008 (suppl; abstr)
21. Whelan T, Levine M, Willan A, et al: Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: A randomized trial. JAMA 292:435-441, 2004
22. O'Brien MA, Whelan TJ, Villasis-Keever M, et al: Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol 27:974-985, 2009
23. Bartelink H, Horiot J-C, Poortmans PM, et al: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259-3265, 2007
24. Romestaing P, Lehingue Y, Carrie C, et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963-968, 1997
25. Mamounas EP, Tang G, Fisher B, et al: Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: Results from NSABP B-14 and NSABP B-20. J Clin Oncol doi: 10.1200/JCO.2009.23.7610
26. Solin LJ, Hwang W-T, Vapiwala N: Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clin Breast Cancer 9:96-100, 2009
27. Freedman GM, Anderson PR, Li T, et al: Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 115:946-951, 2009
28. Haffty BG, Yang Q, Reiss M, et al: Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24:5652-5657, 2006
29. Dent R, Trudeau M, Pritchard KI, et al: Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res 13:4429-4434, 2007 (Pubitemid 47219710)
30. Parikh RR, Yang Q, Higgins SA, et al: Outcomes in young women with breast cancer of triple-negative phenotype: The prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 70:35-42, 2008 (Pubitemid 350251027)
31. Nguyen PL, Taghian AG, Katz MS, et al: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373-2378, 2008
32. Cheang MC, Voduc D, Tyldesley S, et al: Breast cancer molecular subtypes and locoregional recurrence. J Clin Oncol 26:9s, 2008 (suppl; abstr 510)
33. Harris EER, Hwang W-T, Lee EA, et al: The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. Breast J 12:431-436, 2006
34. Haffty BG, Yang Q, Moran MS, et al: Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation. Int J Radiat Oncol Biol Phys 71:1006-1013, 2008
35. Yang Q, Moran MS, Haffty BG: Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy. Breast Cancer Res Treat 115:343-348, 2009
36. Nuyten DSA, Kreike B, Hart AAM, et al: Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8:R62, 2006
37. Kreike B, Halfwerk H, Armstrong N, et al: Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients. Clin Cancer Res 15:4181-4190, 2009
38. Adjuvant! Online. http://adjuvantonline.com
39. Ravdin PM, Siminoff LA, Davis GJ, et al: Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19:980-991, 2001
40. Olivotto IA, Bajdik CD, Ravdin PM, et al: Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23:2716-2725, 2005